|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||225.85 - 233.50|
|52-week range||142.01 - 240.20|
|PE ratio (TTM)||161.65|
|Earnings date||1 Mar 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||227.33|
NEW YORK, Jan. 25, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Hub Group, Inc. (NASDAQ:HUBG), Meridian Bancorp, Inc. (NASDAQ:EBSB), ICU Medical, Inc. (NASDAQ:ICUI), First Merchants Corporation (NASDAQ:FRME), AAC Holdings, Inc. (NYSE:AAC), and Covenant Transportation Group, Inc. (NASDAQ:CVTI), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Illumina (ILMN) harbors hopes about recent launches like NovaSeq S4 flow cell and reagent kit for its NovaSeq 6000 System. A low margin scenario due to the NovaSeq launch is a concern.
Zimmer Biomet (ZBH) fights challenges like supply delay of certain products that curb its capacity to regain lost US-based customers and net in the new ones.
The San Clemente, California-based company said it had profit of 1 cent per share. Earnings, adjusted for non-recurring costs and stock option expense, came to $1.12 per share. The medical device maker ...
ICU Medical (ICUI) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.